Criteria for the selection of patients for surgery for mitral stenosis and for mitral insufficiency are presented with regard to the place of such surgery in the life cycle of these diseases. A brief discussion has been given of the clinical differentiation between mitral stenosis and mitral incompetence, as well as the place of hemodynamic and other laboratory procedures in the evaluation of patients for surgery and of the results of operation. Closed mitral valvuloplasty is the operation of choice in group iii patients without significant valvular calcification or incompetency. This conclusion is based on statistically valid figures which are cited, the low operative mortality of less than 2 per cent, the sustained good results and the excellent life expectancy of these patients. Other patients must be carefully evaluated, and in many, open operations utilizing cardiopulmonary bypass may be preferred. The problems attendant on open cardiac surgery are discussed, and it is concluded that the place of such surgery cannot be definitely defined until long term results are available. The problem of “restenosis” is considered. Although in many patients deterioration after initial improvement is apparently due to an inadequate operation, mitral insufficiency, rheumatic fever or myocardial failure, in others no obvious iactors explain the restenosis. Reoperations for mitral stenosis are required in increasing numbers as the follow-up period increases. After nine years, in our series, 22 per cent of patients have had reoperation. The technic and results from reoperation are briefly mentioned. Patients with predominant mitral stenosis should be offered surgery when their symptoms are becoming progressively worse, or if they have clear-cut evidence of well marked pulmonary hypertension, or if they have had peripheral embolization. Mitral insufficiency is a condition requiring open surgery. The problems in the selection of patients, in evaluating the valve pathology and in the surgery itself are briefly discussed. Because there is no agreement as to the type of patient to be selected for surgery, because the surgical procedures are still in the developmental phase, because operative mortality in symptomatic patients is high, and because long term results are not yet available, surgery for this lesion must be considered to be still in the experimental stage. It should be offered only to those patients with rheumatic mitral incompetence who are symptomatic and whose disease is obviously progressing. Since operative mortality, and probably long term results as well, are directly related to the severity of the illness, the degree of disability and the valvular pathology, it is important that these be clearly set forth in any papers published on this subject; this has often not been done. Finally, the role of primary myocardial failure in the course of rheumatic heart disease, particularly with mitral incompetence, is discussed.